New Diabetes Drug Found Effective

Monday, 07 Jan 2013 12:00 PM

 

  Comment  |
   Contact  |
  Print   |
    A   A  
  Copy Shortlink
Eli Lilly and Co and Boehringer Ingelheim said on Monday that a treatment for Type 2 diabetes, empagliflozin, had been shown to work in four late-stage trials.
The drug aims to reduce blood glucose levels in adults with Type 2 diabetes, the most common form of diabetes in which the body either does not produce enough insulin or the cells ignore the insulin.
About 371 million people worldwide are estimated to have diabetes.
The companies said they expect to file for regulatory review of the drug in the United States, Europe and Japan in 2013 and will present detailed data from the trials this year and next.
The companies said that among adverse reactions, genital infections occurred more often with the treatment than with the placebo.
Boehringer and Lilly are collaborating on several diabetes drugs. On Monday, they said only Lilly would continue with collaboration on another one of the treatments, known as LY2605541.

© HealthDay

  Comment  |
   Contact  |
  Print   |
  Copy Shortlink
Around the Web
Comments
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Country
Zip Code:
Privacy: We never share your email.
 
Find Your Condition
You May Also Like
Around the Web
Most Commented

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAXHEALTH.COM
© Newsmax Media, Inc.
All Rights Reserved
> >